100 mg/vial
Enhertu (Trastuzumab Deruxtecan for Injection) 100mg
Trastuzumab Deruxtecan for Injection
A public medicine summary is being prepared.
Public medicine directory
HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors
Browse public medicine summaries, manufacturers, and approval information for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors.
15 medicinesPage 1 of 2
100 mg/vial; 160 mg/vial.
Kadcyla (trastuzumab emtansine for injection) 100mg; 160mg
Trastuzumab Emtansine for Injection
A public medicine summary is being prepared.
250 mg (10 mL)/vial
Margenza (Margetuximab-cmkb Injection) 250mg
Margetuximab Injection
A public medicine summary is being prepared.
420 mg (14 mL)/vial. Each vial contains 14 mL of concentrate at 30 mg/mL, containing 4